ConsultantLive launches topic center on migraines

UBM Medica's announced today that ConsultantLive now features special coverage focused on helping clinicians diagnose and control migraine headaches.

With the goal of helping clinicians overcome diagnostic pitfalls – while also keeping them abreast of current treatment approaches and regimens – ConsultantLive recently launched its topic center on migraines. Frequent contributor and headache specialist, Susan Hutchinson, MD, offers practical guidance in her new series of podcasts:

  • "Treating Migraine in Primary Care: The Pain is Worth the Gain," which presents practical clinical information on differential diagnosis, medication management, and patient communication
  • "Migraine – When the Headaches Keep on Coming," outlines the factors that underlie to transformation of episodic migraine to refractory migraine
  • "Migraine – 6 Steps to Counter Refractory Headaches," offers simple and effective steps to help patients combat chronic migraine

 Roughly 12 percent of Americans suffer from debilitating, painful migraines – many of which experience three or more per month. With a correct diagnosis there are many effective therapies such as lifestyle changes, awareness of trigger factors and medications. But if busy primary care physicians do not recognize the signs of migraines, many patients who stand to benefit from migraine treatment or therapy may not be receiving it.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Progress in early detection and screening methods for pancreatic cancer